Clinical Trial

Stem Cell and Conditioned Medium for Cerebral Palsy

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated February 25, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study was to compare the effectiveness of umbilical cord mesenchymal stem cells (UCMSCs) and conditioned medium (CM) administration, UCMSCs only and control with standard therapy. Hypothesis: UCMSCs + CM therapy resulting in higher improvement in cognitive function, gross motor function and chemical factors than UCMSCs and standard therapy.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-03-17; most recent amendment 2026-02-23.
Status change: Recruiting → Active, Not Recruiting 2026-02-23
Trial Details
NCT Number NCT04314687
Lead Sponsor PT. Prodia Stem Cell Indonesia
Conditions Cerebral Palsy
Enrollment 78 participants
Start Date 2021-10-13
Primary Completion 2026-07 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-25